Adcetris regimen - a chemo-immunotherapy regimen consisting of brentuximab vedotin that may be used in the treatment of diffuse large b-cell lymphoma (dlbcl) and hodgkin lymphoma (hl).
Up to date info
Latest research - Adcetris regimen
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Adcetris regimen for any updates.